156 related articles for article (PubMed ID: 10482905)
1. The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat.
Chapman V
Br J Pharmacol; 1999 Aug; 127(8):1765-7. PubMed ID: 10482905
[TBL] [Abstract][Full Text] [Related]
2. Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo.
Kelly S; Chapman V
J Neurophysiol; 2001 Dec; 86(6):3061-4. PubMed ID: 11731561
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
[TBL] [Abstract][Full Text] [Related]
5. TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat.
Sagar DR; Smith PA; Millns PJ; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Jul; 20(1):175-84. PubMed ID: 15245490
[TBL] [Abstract][Full Text] [Related]
6. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.
Drew LJ; Harris J; Millns PJ; Kendall DA; Chapman V
Eur J Neurosci; 2000 Jun; 12(6):2079-86. PubMed ID: 10886347
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat.
Hohmann AG; Tsou K; Walker JM
J Neurophysiol; 1999 Feb; 81(2):575-83. PubMed ID: 10036261
[TBL] [Abstract][Full Text] [Related]
8. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Makriyannis A; Hohmann AG
Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
[TBL] [Abstract][Full Text] [Related]
9. Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo.
Harris J; Drew LJ; Chapman V
Neuroreport; 2000 Aug; 11(12):2817-9. PubMed ID: 10976969
[TBL] [Abstract][Full Text] [Related]
10. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation.
Nackley AG; Zvonok AM; Makriyannis A; Hohmann AG
J Neurophysiol; 2004 Dec; 92(6):3562-74. PubMed ID: 15317842
[TBL] [Abstract][Full Text] [Related]
11. Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation.
Kelly S; Jhaveri MD; Sagar DR; Kendall DA; Chapman V
Eur J Neurosci; 2003 Oct; 18(8):2239-43. PubMed ID: 14622184
[TBL] [Abstract][Full Text] [Related]
12. Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats.
Sokal DM; Elmes SJ; Kendall DA; Chapman V
Neuropharmacology; 2003 Sep; 45(3):404-11. PubMed ID: 12871657
[TBL] [Abstract][Full Text] [Related]
13. CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord.
Lever IJ; Malcangio M
Br J Pharmacol; 2002 Jan; 135(1):21-4. PubMed ID: 11786475
[TBL] [Abstract][Full Text] [Related]
14. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
[TBL] [Abstract][Full Text] [Related]
15. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
Welch SP; Huffman JW; Lowe J
J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
[TBL] [Abstract][Full Text] [Related]
16. The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats.
Ellington HC; Cotter MA; Cameron NE; Ross RA
Neuropharmacology; 2002 Jun; 42(7):966-75. PubMed ID: 12069907
[TBL] [Abstract][Full Text] [Related]
17. CB1 receptor mediated analgesia from the Nucleus Reticularis Gigantocellularis pars alpha is activated in an animal model of neuropathic pain.
Monhemius R; Azami J; Green DL; Roberts MH
Brain Res; 2001 Jul; 908(1):67-74. PubMed ID: 11457432
[TBL] [Abstract][Full Text] [Related]
18. SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists.
Costa B; Colleoni M
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1103-8. PubMed ID: 11189200
[TBL] [Abstract][Full Text] [Related]
19. SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.
Richardson JD; Aanonsen L; Hargreaves KM
Eur J Pharmacol; 1997 Jan; 319(2-3):R3-4. PubMed ID: 9042616
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid receptor agonist, WIN 55,212-2, inhibits cool-specific lamina I medullary dorsal horn neurons.
Ogawa A; Meng ID
Neuroscience; 2006 Nov; 143(1):265-72. PubMed ID: 16949215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
